FDA Approves Ibtrozi (taletrectinib) for ROS1-Positive Non-Small Cell Lung Cancer
FDA Approves New Once-Daily Pill for a Type of Lung Cancer
The FDA approved Ibtrozi (taletrectinib) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. The kinase…
The FDA approved Ibtrozi (taletrectinib) for adults with advanced or metastatic non-small cell lung cancer that tests positive for a ROS1 ge…
Early Palliative Care Improves Quality of Life and May Extend Survival in Cancer
Early palliative care improves quality of life for cancer patients
This meta-analysis of 8399 adults with cancer found that early palliative care, started within 12 weeks of diagnosis or first-line treatment…
Starting palliative care early can improve quality of life and may extend survival for people living with cancer.
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer
Weekly cisplatin treatment shows promise for head and neck cancer
A randomized trial confirms that weekly cisplatin dosing achieves noninferiority in overall survival for high-risk squamous cell carcinoma p…
A new trial shows that giving chemotherapy weekly instead of every three weeks may offer a comparable survival rate for head and neck cancer…
MITF E318K variant associated with significantly increased melanoma risk and high nevus burden
Specific gene variant linked to higher risk of multiple melanomas
This systematic review and meta-analysis of 8,606 melanoma patients and 17,953 controls identifies the MITF E318K variant as a moderate-pene…
A specific genetic variant called MITF E318K is linked to a significantly higher risk of developing multiple primary melanomas.
Semaglutide weight loss is greater in females and those with a hungry gut phenotype
Semaglutide Weight Loss Varies by Gender and Specific Health Traits
This mini review synthesizes evidence on semaglutide for weight loss in individuals with obesity and type 2 diabetes. Findings indicate high…
New research shows that factors like gender and specific gut traits can influence how much weight a person loses while taking semaglutide.
NALIRIFOX shows no significant difference in overall survival compared to FOLFIRINOX in pancreatic cancer
NALIRIFOX Shows Similar Survival Rates to FOLFIRINOX for Pancreatic Cancer
This meta-analysis of reconstructed individual patient data evaluated NALIRIFOX versus FOLFIRINOX and mFOLFIRINOX in treatment-naïve patient…
A new analysis shows NALIRIFOX offers similar survival rates to FOLFIRINOX for advanced pancreatic cancer while having different side effect…
PARP inhibitor maintenance improves progression-free survival in advanced ovarian cancer with HRD-positive status
PARP Inhibitors Show Benefit for Advanced Ovarian Cancer Patients
This network meta-analysis of 3,930 patients evaluated PARP inhibitor monotherapy and combination therapies for advanced ovarian, fallopian …
PARP inhibitor-based maintenance significantly improves progression-free survival for patients with advanced ovarian, fallopian tube, or per…
Moxibustion and auricular acupressure significantly reduce cancer-related fatigue in lung cancer patients
Moxibustion and Ear Acupressure May Ease Cancer Fatigue
This network meta-analysis of 32 RCTs indicates that moxibustion and auricular acupressure are more effective than usual care or qigong for …
A new review suggests moxibustion and ear acupressure may help tiredness in lung cancer patients, but the evidence is still shaky.
OCT and fluorescence-guided imaging show highest clinical translation among biophotonic methods in veterinary medicine
Biophotonics Offer New Ways to Image Veterinary Cancer Patients
This perspective review examines biophotonics technologies, including OCT and fluorescence-guided imaging, for veterinary applications. The …
New imaging technologies like optical coherence tomography may help veterinarians see and monitor tumors without invasive procedures or heav…
Dermatomyositis with breast cancer regresses on glucocorticoids and paclitaxel in single case
New findings link dermatomyositis and breast cancer in one patient
This is a single case report of a 48-year-old woman with dermatomyositis and breast cancer whose skin lesions markedly regressed, muscle str…
A woman with dermatomyositis and breast cancer saw significant improvements in skin, muscle strength, and swallowing after treatment.
Melanoma Immunoediting Review Maps Elimination, Equilibrium, Escape and Drivers of Immunotherapy Resistance
Immune System Changes Drive Melanoma Growth and Treatment Resistance
This systematic review synthesizes the tumor immunoediting framework in melanoma, describing three sequential phases (elimination, equilibri…
New research highlights how the immune system's failure to eliminate melanoma cells leads to tumor growth and resistance to current therapie…
Medial cavernous sinus wall resection achieves 85% endocrine remission in functioning pituitary adenomas
Surgery Technique Shows High Success for Pituitary Tumor Treatment
This meta-analysis of 493 patients with functioning pituitary adenomas found that medial cavernous sinus wall resection (MCSWR) is associate…
A surgical technique called MCSWR shows high rates of hormone remission and tumor removal for patients with specific pituitary gland tumors.